Resultados de la búsqueda 161-170 of 23165 for Two-phase

  1. Clínica de las mamas - Ensayos clínicos - Mayo Clinic

    Phase Ib Study of Axatilimab in Combination with Olaparib in BRCA1/2 and PALB2- Associated Metastatic HER2-negative Breast Cancer. Rochester, Minn. This ...

  2. Oncología (médica) - Ensayos clínicos - Mayo Clinic

    ... phase 2 dose (RP2D) and preferred schedule, and assess preliminary anti-tumor activity. A Study to Test the Effectiveness of Two Immunotherapy Drugs ...

  3. Cirugía - Ensayos clínicos - Mayo Clinic

    Randomized Phase II/III Trial of Adjuvant ... two anti-hypertensive medications and lifestyle changes. ... Ir a página 22 · Ir a página 33 · Ir a página 44 ...

  4. Oncología (médica) - Ensayos clínicos - Mayo Clinic

    The primary objective of Part 1 of this study is to define the maximum tolerated dose (MTD) and/or the recommended Phase 2 dose (RP2D) of CC-220 in ...

  5. Oncología (médica) - Ensayos clínicos - Mayo Clinic

    This phase II trials studies how well ... two lines of therapy as measured by objective ... This phase I/II trial studies the side effects and best ...

  6. Hematología - Ensayos clínicos - Mayo Clinic

    1) in patients with relapsed and/or refractory diffuse large B cell lymphoma (DLBCL) after receiving at least two lines of therapy. ... This phase II trials ...

  7. Hematología - Ensayos clínicos - Mayo Clinic

    ABBV-383 is an investigational drug being developed for the treatment of R/R Multiple Myeloma (MM). This study includes 2 parts; step-up dose optimization (Part ...

  8. Oncología (médica) - Ensayos clínicos - Mayo Clinic

    ... phase 2 dose (RP2D) and preferred schedule, and assess preliminary anti-tumor activity. A Study to Test the Effectiveness of Two Immunotherapy Drugs ...

  9. Oncología (médica) - Ensayos clínicos - Mayo Clinic

    ... Phase 2 dose (RP2D) for \[177Lu\]Lu FAP 2286 monotherapy in participants with FAP expressing solid tumors. Phase 2 is designed to evaluate the safety and ...

  10. Hematología - Ensayos clínicos - Mayo Clinic

    ABBV-383 is an investigational drug being developed for the treatment of R/R Multiple Myeloma (MM). This study includes 2 parts; step-up dose optimization (Part ...